News-Guangdong Hecin Scientific,Inc.

News Popular Science

2024.05.31

Epidemic strains of hand, foot and mouth disease virus are evolving

Recently, the China CDC Weekly Report released a research study on HFMD viruses, which showed that Coxsackievirus A6 (CV-A6) has become the major pathogen causing severe cases of HFMD in China. This finding is of widespread concern because Coxsackievirus A6, which is associated with severe HFMD, is evolving and is at risk for outbreaks.

View Details

Li Chenyang: "Virus Hunter" True heroes show their true colors in times of crisis

During the May Day Labor Day, Li Chenyang, our deputy general manager and director of R&D, was reported by major news websites. In the series of reports launched by the news websites "Salute to Workers for Resuming Production in the Fight against the Epidemic", Mr. Li, as a representative of biopharmaceutical companies , highly praised.

2020.05.08

082020.05

Warmly welcome professors from Guangzhou Medical University to visit our company for exchanges

Recently, Professor Lu Wenju, Director of the Project Team of the State Key Laboratory of Respiratory Diseases of Guangzhou Medical University, Professor Sun Baoqing, Director of the Office of the Institute of Respiratory Health of the First Affiliated Hospital of Guangzhou Medical University, and other people visited our company.

2020.05.08

082020.05

Hecin Health’s new coronavirus on-site rapid diagnostic reagent was recommended by the country and entered the emergency approval channel

In order to further strengthen the scientific and technological support for the development of new coronavirus testing products for epidemic prevention and control, the Ministry of Science and Technology, together with the Food and Drug Administration, released the "Novel Coronavirus (2019-nCoV) Rapid Testing Product Development" project application guide on February 8.Guangdong Hecin Scientific, Inc. responded positively and quickly handed over the new coronavirus on-site rapid diagnostic reagent solution. On February 19, the project was recommended by the Office of the Joint Prevention and Control Mechanism (Scientific Research Group) of the State Council to respond to the new coronavirus epidemic and was included in the emergency approval channel.

2020.02.20

202020.02

Innovative solution for novel coronavirus prevention and control-respiratory pathogen sample inactivation preservation solution

In the process of fighting the pneumonia epidemic caused by the new coronavirus infection, there are three major pain points in the sample collection, storage, and transportation processes. First, patients are concentrated in fever clinics for sampling, and patients are the largest source of infection; second, existing sample storage and transportation methods It is highly contagious and requires professional and technical personnel to operate and cold chain transportation; third, the samples have potential infection risks for testing personnel. In order to solve the existing problems, Guangdong Hecin Scientific, Inc., together with the State Key Laboratory of Respiratory Diseases and the National Clinical Research Center for Respiratory Diseases, innovatively developed an inactivated preservation solution for respiratory pathogen samples based on the actual needs of the epidemic.

2020.01.30

302020.01

« 1 2 3 4 5 »